First Trust Nasdaq Pharmaceuticals ETF
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
AMEX · UPW · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ProShares Ultra Utilities’s quoted price sits in the lower half of its reported 52-week range, 19.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ProShares Ultra Utilities’s forward annual dividend is $0.52 per share, paid quarterly. The forward yield is 2.41% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
UPW provides 2x leveraged exposure to the S&P Utilities Select Sector Index, a market cap-weighted index of US utilities companies drawn exclusively from the S&P 500. The index includes the following GICS industries: electric, gas, water, and multi-utilities, independent power, and renewable electricity producers. UPW is designed as a short-term trading vehicle, not a long-term investment. It holds swap agreements and resets on a daily basis. As a result, compounding and path dependency make long-term returns difficult to predict when compared with the performance of its underlying index. Prior to March 20, 2023, the fund tracked the Dow Jones US Utilities Index.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 05:42 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$44.24+$0.47 (+1.07%)
First Trust Nasdaq Pharmaceuticals ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$41.79-$0.70 (-1.64%)
iShares LifePath Target Date 2065 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.38% below the high.
$47.86-$0.25 (-0.52%)
Leuthold Select Industries ETF’s quoted price sits in the upper half of its reported 52-week range, 6.8% below the high.
$77.25-$2.99 (-3.73%)
Putnam Emerging Markets Ex-China ETF’s quoted price sits in the lower half of its reported 52-week range, 18.85% below the high.
$32.24-$0.56 (-1.71%)
AllianzIM U.S. Equity 6 Month Buffer10 May/Nov ETF’s quoted price sits in the upper half of its reported 52-week range, 1.92% below the high.
$35.26-$0.68 (-1.89%)
Infrastructure Capital Small Cap Income ETF’s quoted price sits in the lower half of its reported 52-week range, 12.38% below the high.
$37.44$0.00 (0.0%)
Rayliant SMDAM Japan Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 10.67% below the high.
$26.57-$0.05 (-0.19%)
Hedgeye Capital Allocation ETF’s quoted price sits in the lower half of its reported 52-week range, 14.01% below the high.